Srijan Acharya

467 total citations
32 papers, 353 citations indexed

About

Srijan Acharya is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Srijan Acharya has authored 32 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 15 papers in Cellular and Molecular Neuroscience and 4 papers in Organic Chemistry. Recurrent topics in Srijan Acharya's work include Receptor Mechanisms and Signaling (11 papers), Neuroscience and Neuropharmacology Research (7 papers) and Neurotransmitter Receptor Influence on Behavior (6 papers). Srijan Acharya is often cited by papers focused on Receptor Mechanisms and Signaling (11 papers), Neuroscience and Neuropharmacology Research (7 papers) and Neurotransmitter Receptor Influence on Behavior (6 papers). Srijan Acharya collaborates with scholars based in South Korea, United States and China. Srijan Acharya's co-authors include Kyeong‐Man Kim, Anuradha S. Nerurkar, Anoop R. Markande, Seung Hoon Cheon, Xiaohan Zhang, Goo Yoon, Xiao Min, Ajay P. Singh, Mohammad Aslam Khan and Ningning Sun and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Srijan Acharya

30 papers receiving 347 citations

Peers

Srijan Acharya
Srijan Acharya
Citations per year, relative to Srijan Acharya Srijan Acharya (= 1×) peers Ewelina Honkisz-Orzechowska

Countries citing papers authored by Srijan Acharya

Since Specialization
Citations

This map shows the geographic impact of Srijan Acharya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Srijan Acharya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Srijan Acharya more than expected).

Fields of papers citing papers by Srijan Acharya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Srijan Acharya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Srijan Acharya. The network helps show where Srijan Acharya may publish in the future.

Co-authorship network of co-authors of Srijan Acharya

This figure shows the co-authorship network connecting the top 25 collaborators of Srijan Acharya. A scholar is included among the top collaborators of Srijan Acharya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Srijan Acharya. Srijan Acharya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Anand, Shashi, et al.. (2024). Smokeless Tobacco: A Comprehensive Review of Molecular Effects, Societal Perception, and Cessation Strategies. SHILAP Revista de lepidopterología. 4(4). 446–463.
2.
Acharya, Srijan, et al.. (2024). Unveiling the intracellular dynamics of α4β2 nAChR-mediated ERK activation through the interplay of arrestin, Gβγ, and PKCβII. Life Sciences. 355. 122994–122994. 1 indexed citations
3.
Liu, Haiping, Srijan Acharya, Sarabjeet Kour Sudan, et al.. (2023). Comparative study of the molecular mechanisms underlying the G protein and β‐arrestin‐dependent pathways that lead to ERKs activation upon stimulation by dopamine D 2 receptor. FEBS Journal. 290(21). 5204–5233. 4 indexed citations
4.
Liu, Haiping, et al.. (2023). Ubiquitination of GRK2 Is Required for the β-Arrestin-Biased Signaling Pathway of Dopamine D2 Receptors to Activate ERK Kinases. International Journal of Molecular Sciences. 24(12). 10031–10031. 7 indexed citations
5.
Khan, Mohammad Aslam, Srijan Acharya, Shashi Anand, et al.. (2023). MYB exhibits racially disparate expression, clinicopathologic association, and predictive potential for biochemical recurrence in prostate cancer. iScience. 26(12). 108487–108487. 6 indexed citations
6.
Acharya, Srijan, Mohammad Aslam Khan, Furhan Yunus, et al.. (2023). Abstract 3318: Frequent loss of CACNA1C, a calcium voltage-gated channel subunit is associated with lung adenocarcinoma progression and poor prognosis. Cancer Research. 83(7_Supplement). 3318–3318. 4 indexed citations
7.
Acharya, Srijan, Shashi Anand, Mohammad Aslam Khan, et al.. (2022). Biphasic transcriptional and posttranscriptional regulation of MYB by androgen signaling mediates its growth control in prostate cancer. Journal of Biological Chemistry. 299(1). 102725–102725. 7 indexed citations
8.
Srivastava, Sanjeev K., Mohammad Aslam Khan, Srijan Acharya, et al.. (2021). Clinicopathologic significance and race-specific prognostic association of MYB overexpression in ovarian cancer. Scientific Reports. 11(1). 12901–12901. 9 indexed citations
9.
Zheng, Mei, Xiaohan Zhang, Ningning Sun, et al.. (2020). A novel molecular mechanism responsible for phosphorylation-independent desensitization of G protein-coupled receptors exemplified by the dopamine D3 receptor. Biochemical and Biophysical Research Communications. 528(3). 432–439. 7 indexed citations
10.
Acharya, Srijan, et al.. (2020). Metabotropic signaling cascade involved in α4β2 nicotinic acetylcholine receptor-mediated PKCβII activation. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1867(8). 118721–118721. 12 indexed citations
12.
Acharya, Srijan & Kyeong‐Man Kim. (2019). α4β2 nicotinic acetylcholine receptor downregulates D3 dopamine receptor expression through protein kinase C activation. Biochemical and Biophysical Research Communications. 514(3). 665–671. 8 indexed citations
13.
Min, Xiao, Xiaohan Zhang, Ningning Sun, Srijan Acharya, & Kyeong‐Man Kim. (2019). Mdm2-mediated ubiquitination of PKCβII in the nucleus mediates clathrin-mediated endocytic activity. Biochemical Pharmacology. 170. 113675–113675. 17 indexed citations
14.
Min, Xiao, Srijan Acharya, Daulat Bikram Khadka, et al.. (2018). Design, synthesis, and systematic evaluation of 4-arylpiperazine- and 4-benzylpiperidine napthyl ethers as inhibitors of monoamine neurotransmitters reuptake. Bioorganic & Medicinal Chemistry. 26(20). 5538–5546. 3 indexed citations
15.
Acharya, Srijan, et al.. (2017). Design, synthesis and in vitro activity of 1,4-disubstituted piperazines and piperidines as triple reuptake inhibitors. Bioorganic & Medicinal Chemistry. 25(7). 2266–2276. 13 indexed citations
16.
Min, Xiao, Srijan Acharya, Daulat Bikram Khadka, et al.. (2017). Triple reuptake inhibitors: Design, synthesis and structure–activity relationship of benzylpiperidine–tetrazoles. Bioorganic & Medicinal Chemistry. 25(20). 5278–5289. 19 indexed citations
17.
Acharya, Srijan, et al.. (2016). Design, synthesis, and biological evaluation of arylpiperazine–benzylpiperidines with dual serotonin and norepinephrine reuptake inhibitory activities. Bioorganic & Medicinal Chemistry. 24(9). 2137–2145. 12 indexed citations
18.
Acharya, Srijan, et al.. (2016). Exploration of substituted arylpiperazine–tetrazoles as promising dual norepinephrine and dopamine reuptake inhibitors. Bioorganic & Medicinal Chemistry. 24(21). 5546–5555. 11 indexed citations
19.
Cao, Yongkai, Chengchun Min, Srijan Acharya, Kyeong‐Man Kim, & Seung Hoon Cheon. (2015). Design, synthesis and evaluation of bitopic arylpiperazinephenyl-1,2,4-oxadiazoles as preferential dopamine D3 receptor ligands. Bioorganic & Medicinal Chemistry. 24(2). 191–200. 15 indexed citations
20.
Acharya, Srijan, et al.. (2013). Medicinal activities of the leaves of Musa sapientum var. sylvesteris in vitro. Asian Pacific Journal of Tropical Biomedicine. 3(6). 476–482. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026